Cited by 2,586Protein Kinase Regulation and GTPase SignalingReceptor Mechanisms and SignalingPI3K/AKT/mTOR signaling in cancer

Signaling—2000 and Beyond

Open access
Hunter, Tony·2000·Cell

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0092-8674(00)81688-8

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Microglial Nox1 and Nox2 target different redox-sensitive signaling compounds, possibly because of differences in the subcellular distributions of catalytically active Nox and LPS-signaling components.

    “differential effects of Nox proteins in microglial expression of IL-1␤ and iNOS genes suggest that microglial Nox1 and Nox2 target different redoxsensitive signaling compounds, possibly because of differences in the subcellular distributions of catalytically active Nox and LPSsignaling components (Hunter, 2000).”

    From Neurotoxic Activation of Microglia Is Promoted by a Nox1-Dependent NADPH Oxidase (2008) · cites this paper as Hunter, 2000

    The section “Spatiotemporal Aspects of Signaling” (page unavailable) says that the location of signaling components can determine signaling specificity, supporting the proposed spatial mechanism in general. It does not address microglial Nox1 or Nox2, their redox-sensitive targets, or LPS-signaling components, so it does not support the specific application to them. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [1]1. Adams, P.D ∙ Sellers, W.R ∙ Sharma, S.K ... Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors Mol. Cell. Biol. 1996; 16:6623-6633 Crossref Scopus (319) PubMed Google Scholar
  2. [2]2. Artavanis-Tsakonas, S ∙ Rand, M.D ∙ Lake, R.J Notch signalingcell fate control and signal integration in development Science. 1999; 284:770-776 Crossref Scopus (5115) PubMed Google Scholar
  3. [3]3. Austin, D.J ∙ Crabtree, G.R ∙ Schreiber, S.L Proximity versus allosterythe role of regulated protein dimerization in biology Chem. Biol. 1994; 1:131-136

Cited by

Sorted by citations

Authors
Hunter, T.
Affiliations
Salk Institute for Biological Studies (US)
Corresponding author
Hunter, Tony
Venue
Cell
Publisher
Elsevier BV
Published
2000-01
Volume
100
Issue
1
Pages
113-127
ISSN
0092-8674 (ISSN-L)
OpenAlex
W2042629507
Cited by
2,586
References
5
Citations by year
2026: 34 · 2025: 40 · 2024: 43 · 2023: 39 · 2022: 47 · 2021: 43 · 2020: 41 · 2019: 55 · 2018: 70 · 2017: 93 · 2016: 69 · 2015: 101 · 2014: 91 · 2013: 100 · 2012: 119
FWCI
11.30
Type
journal article
Language
en
Open access
Locations
  • Cell (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords
signal transduction, G proteins, cyclic AMP, protein kinase A, second messengers, transmembrane signaling, protein phosphorylation, protein kinases, protein phosphatase, adenylate cyclase, receptor tyrosine kinase, MAP kinase cascade, MAP3K, MEK, mitogen-activated protein kinase, cancer signaling
MeSH terms
Animals, Biology, Forecasting, Humans, Signal Transduction, History, 20th Century

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review